Patents by Inventor Ali Ates

Ali Ates has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Prodrugs of 2-(3,5-Dichloro-1-methyl-indazol-4-yl)-1-[(1S,3R)-3-(hydroxymethyl)-5-(1-hydroxy-1-methyl-ethyl)-1-methyl-3,4-dihydro-1H-isoquinolin-2-yl]ethanone
    Publication number: 20240083925
    Abstract: The present invention relates to a prodrug of 2-(3,5-dichloro-1-methyl-indazol-4-yl)-1-[(1S,3R)-3-(hydroxymethyl)-5-(1-hydroxy-1-methyl-ethyl)-1-methyl-3,4-dihydro-1H-isoquinolin-2-yl]ethanone, which prodrug is represented by formula (II).
    Type: Application
    Filed: December 16, 2021
    Publication date: March 14, 2024
    Inventors: Ali Ates, Celal Ates, Laurent Provins
  • Octahydroisoquinolinyl Derivatives
    Publication number: 20240043400
    Abstract: The present invention relates to octahydroisoquinolinyl derivatives according to formula (I), which are Positive Allosteric Modulators of D1 and accordingly of benefit as pharmaceutical agents for the treatment of diseases in which D1 receptors play a role.
    Type: Application
    Filed: December 1, 2021
    Publication date: February 8, 2024
    Inventors: Ali Ates, Pierre Burssens, Adrian Hall, Laurent Provins, David Skolc, Anne Valade
  • A Substituted Tetrahydroisoquinoiline Derivative as a D1 Positive Allosteric Modulator
    Publication number: 20220259179
    Abstract: The present invention relates to compound according to formula (I), (I) which is a positive allosteric modulator of D1 and accordingly of benefit as pharmaceutical agent for the treatment of diseases in which D1 receptors play a role.
    Type: Application
    Filed: June 29, 2020
    Publication date: August 18, 2022
    Inventors: Ali Ates, David Skolc
  • Tetrahydroisoquinoline derivatives
    Patent number: 10370355
    Abstract: The present invention relates to tetrahydroisoquinoline derivatives according to formula (I), wherein G represents a fused heterocyclic system selected from the groups represented by formula (G1), (G2), (G3), (G4), (G5), and (G6), which are Positive Allosteric Modulators of D1 and accordingly of benefit as pharmaceutical agents for the treatment of diseases in which D1 receptors play a role.
    Type: Grant
    Filed: April 7, 2017
    Date of Patent: August 6, 2019
    Assignee: UCB BIOPHARMA SPRL
    Inventors: Ali Ates, Eric Jnoff, Laurent Provins, Anne Valade, Adrian Hall
  • Tetrahydroisoquinoline Derivatives
    Publication number: 20190106406
    Abstract: The present invention relates to tetrahydroisoquinoline derivatives according to formula (I), wherein G represents a fused heterocyclic system selected from the groups represented by formula (G1), (G2), (G3), (G4), (G5), and (G6), which are Positive Allosteric Modulators of D1 and accordingly of benefit as pharmaceutical agents for the treatment of diseases in which D1 receptors play a role.
    Type: Application
    Filed: April 7, 2017
    Publication date: April 11, 2019
    Inventors: Ali Ates, Eric Jnoff, Laurent Provins, Anne Valade, Adrian Hall
  • Tetrahydroisoquinoline derivatives
    Patent number: 10105359
    Abstract: The present invention relates to tetrahydroisoquinoline derivatives according to formula (I), which are Positive Allosteric Modulators of D1 and accordingly of benefit as pharmaceutical agents for the treatment of diseases in which D1 receptors play a role.
    Type: Grant
    Filed: October 6, 2015
    Date of Patent: October 23, 2018
    Assignee: UCB BIOPHARMA SPRL
    Inventors: Anne Valade, Eric Jnoff, Ali Ates, Pierre Burssens, David Skolc, Zara Sands, Benoit Mathieu
  • Isoindoline derivatives
    Patent number: 9975873
    Abstract: The present invention relates to isoindoline derivatives according to formula (I), which are Positive Allosteric Modulators of D1 and accordingly of benefit as pharmaceutical agents for the treatment of diseases in which D1 receptors play a role.
    Type: Grant
    Filed: October 6, 2015
    Date of Patent: May 22, 2018
    Assignee: UCB BIOPHARMA SPRL
    Inventors: David Skolc, Ali Ates, Eric Jnoff, Anne Valade, Benoit Mathieu, Zara Sands
  • Isoindoline Derivatives
    Publication number: 20170313677
    Abstract: The present invention relates to isoindoline derivatives according to formula (I), which are Positive Allosteric Modulators of D1 and accordingly of benefit as pharmaceutical agents for the treatment of diseases in which D1 receptors play a role.
    Type: Application
    Filed: October 6, 2015
    Publication date: November 2, 2017
    Inventors: David Skolc, Ali Ates, Eric Jnoff, Anne Valade, Benoit Mathieu, Zara Sands
  • Tetrahydroisoquinoline Derivatives
    Publication number: 20170304292
    Abstract: The present invention relates to tetrahydroisoquinoline derivatives according to formula (I), which are Positive Allosteric Modulators of D1 and accordingly of benefit as pharmaceutical agents for the treatment of diseases in which D1 receptors play a role.
    Type: Application
    Filed: October 6, 2015
    Publication date: October 26, 2017
    Inventors: Anne VALADE, Eric JNOFF, Ali ATES, Pierre BURSSENS, David SKOLC, Zara SANDS, Benoit MATHIEU
  • 2-oxo-piperidinyl derivatives
    Patent number: 9067930
    Abstract: The present invention relates to 2-oxo-piperidinyl derivatives, processes for preparing them, pharmaceutical compositions containing them and their use as pharmaceuticals.
    Type: Grant
    Filed: October 10, 2012
    Date of Patent: June 30, 2015
    Assignee: UCB Pharma, S.A.
    Inventors: Ali Ates, Florian Montel, Anne Valade, Olivier Lorthioir
  • 2-Oxo-Piperidinyl Derivatives
    Publication number: 20150011526
    Abstract: The present invention relates to 2-oxo-piperidinyl derivatives, processes for preparing them, pharmaceutical compositions containing them and their use as pharmaceuticals.
    Type: Application
    Filed: October 10, 2012
    Publication date: January 8, 2015
    Inventors: Ali Ates, Florian Montel, Anne Valade, Olivier Lorthioir
  • 2-oxo-1-pyrrolidine derivatives, processes for preparing them and their uses
    Patent number: 8586623
    Abstract: The present invention concerns 2-oxo-1-pyrrolidine derivatives, processes for preparing them, pharmaceutical compositions containing them and their use as pharmaceuticals.
    Type: Grant
    Filed: April 6, 2012
    Date of Patent: November 19, 2013
    Assignee: UCB Pharma, S.A.
    Inventors: Benoit Kenda, Yannick Quesnel, Ali Ates, Philippe Michel, Laurent Turet, Joel Mercier
  • 2-oxo-1-pyrrolidine derivatives, processes for preparing them and their uses
    Patent number: 8518943
    Abstract: The present invention concerns 2-oxo-1-pyrrolidine derivatives, processes for preparing them, pharmaceutical compositions containing them and their use as pharmaceuticals.
    Type: Grant
    Filed: April 6, 2012
    Date of Patent: August 27, 2013
    Assignee: UCB Pharma, S.A.
    Inventors: Benoit Kenda, Yannick Quesnel, Ali Ates, Philippe Michel, Laurent Turet, Joel Mercier
  • 2-Oxo-1-Pyrrolidine Derivatives, Processes for Preparing Them and Their Uses
    Publication number: 20120214815
    Abstract: The present invention concerns 2-oxo-1-pyrrolidine derivatives, processes for preparing them, pharmaceutical compositions containing them and their use as pharmaceuticals.
    Type: Application
    Filed: April 6, 2012
    Publication date: August 23, 2012
    Applicant: UCB Pharma, S.A.
    Inventors: Benoît KENDA, Yannick QUESNEL, Ali ATES, Philippe MICHEL, Laurent TURET, Joël MERCIER
  • 2-Oxo-1-Pyrrolidine Derivatives, Processes for Preparing Them and Their Uses
    Publication number: 20120196866
    Abstract: The present invention concerns 2-oxo-1-pyrrolidine derivatives, processes for preparing them, pharmaceutical compositions containing them and their use as pharmaceuticals.
    Type: Application
    Filed: April 6, 2012
    Publication date: August 2, 2012
    Applicant: UCB PHARMA, S.A.
    Inventors: Benoît Kenda, Yannick Quesnel, Ali Ates, Philippe Michel, Laurent Turet, Joël Mercier
  • 2-oxo-1-pyrrolidine derivatives
    Patent number: 8183241
    Abstract: The present invention concerns 2-oxo-1-pyrrolidine derivatives, processes for preparing them, pharmaceutical compositions containing them and their use as pharmaceuticals.
    Type: Grant
    Filed: May 31, 2006
    Date of Patent: May 22, 2012
    Assignee: UCB Pharma, S.A.
    Inventors: Benoît Kenda, Yannick Quesnel, Ali Ates, Philippe Michel, Laurent Turet, Joël Mercier
  • 2-oxo-1-pyrrolidine derivatives, processes for preparing them and their uses
    Patent number: 8178533
    Abstract: The present invention concerns 2-oxo-1-pyrrolidine derivatives, processes for preparing them, pharmaceutical compositions containing them and their use as pharmaceuticals.
    Type: Grant
    Filed: May 31, 2006
    Date of Patent: May 15, 2012
    Assignee: UCB Pharma, S.A.
    Inventors: Benoît Kenda, Yannick Quesnel, Ali Ates, Philippe Michel, Laurent Turet, Joël Mercier
  • New Heterocyclic Derivatives Useful For The Treatment of CNS Disorders
    Publication number: 20100222326
    Abstract: The present invention relates to new compounds, processes for preparing them, pharmaceutical compositions containing them and their use as pharmaceuticals.
    Type: Application
    Filed: April 24, 2008
    Publication date: September 2, 2010
    Applicant: UCB PHARMA, S.A.
    Inventors: Benoit Kenda, Laurent Turet, Yannick Quesnel, Philippe Michel, Ali Ates
  • 2-Oxo-1-Pyrrolidine Derivatives, Processes for Preparing Them and Their Uses
    Publication number: 20090312333
    Abstract: The present invention concerns 2-oxo-1-pyrrolidine derivatives, processes for preparing them, pharmaceutical compositions containing them and their use as pharmaceuticals.
    Type: Application
    Filed: May 31, 2006
    Publication date: December 17, 2009
    Applicant: UCB PHARMA, S.A.
    Inventors: Benoît Kenda, Yannick Quesnel, Ali Ates, Philippe Michel, Laurent Turet, Joel Mercier
  • 2-OXO-1-PYRROLIDINE DERIVATIVES
    Publication number: 20090156607
    Abstract: The present invention concerns 2-oxo-1-pyrrolidine derivatives, processes for preparing them, pharmaceutical compositions containing them and their use as pharmaceuticals.
    Type: Application
    Filed: May 31, 2006
    Publication date: June 18, 2009
    Applicant: UCB, S.A.
    Inventors: Benoit Kenda, Yannick Quesnel, Ali Ates, Philippe Michel, Laurent Turet, Joel Mercier